NEW YORK (GenomeWeb News) — Shareholders and option holders in Tm Bioscience have approved a plan by Luminex to buy the Canadian company, Tm said today.
 
The company said the acquisition now will go before an Ontario Superior Court Justice for review on Feb. 27. If the court approves the deal it should close the following day, Tm said.
 
The acquisition was originally announced last December.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.